Burning Rock Biotech Ltd financial data

Symbol
BNR on Nasdaq
Industry
Services-Medical Laboratories
Location
No. 5 Xingdao Ring Road North,, International Bio Island, Guangzhou, Guangdong, China
Latest financial report
Q4 2023 - Apr 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Operating Margin -125 % +28.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 75.7M USD -7.31%
Cost of Revenue 24.5M USD -7.62%
Research and Development Expense 48.9M USD -20.1%
Selling and Marketing Expense 34.9M USD -35%
General and Administrative Expense 61.7M USD -25.2%
Operating Income (Loss) -94.3M USD +33.7%
Income Tax Expense (Benefit) 336K USD +16.7%
Net Income (Loss) Attributable to Parent -92.1M USD +34.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 86.6M USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current 17.9M USD +12.1%
Inventory, Net 9.72M USD -48.6%
Assets, Current 125M USD -31.8%
Property, Plant and Equipment, Net 18.6M USD -49.1%
Operating Lease, Right-of-Use Asset 1.73M USD -75.2%
Intangible Assets, Net (Excluding Goodwill) 136K USD -52.8%
Other Assets, Noncurrent 718K USD -76.3%
Assets 146M USD -36.4%
Accounts Payable, Current 2.54M USD -65.6%
Employee-related Liabilities, Current 7.16M USD -30.4%
Liabilities, Current 37.1M USD -37.8%
Operating Lease, Liability, Noncurrent 520K USD -73.5%
Other Liabilities, Noncurrent 638K USD +6.69%
Liabilities 38.3M USD -38.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -22.8M USD +5.31%
Retained Earnings (Accumulated Deficit) -543M USD -17%
Stockholders' Equity Attributable to Parent 108M USD -35.6%
Liabilities and Equity 146M USD -36.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36M USD +45.6%
Net Cash Provided by (Used in) Financing Activities -6.88M USD +45%
Net Cash Provided by (Used in) Investing Activities -1.31M USD -21%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -43.7M USD +41.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 86.7M USD -33.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 75.4M USD +19.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.25 pure 0%
Deferred Tax Assets, Gross 75.8M USD +16.1%
Operating Lease, Liability 1.74M USD -76.4%
Depreciation 18.5M USD +5.76%
Payments to Acquire Property, Plant, and Equipment 1.14M USD -87.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91.5M USD +32.1%
Lessee, Operating Lease, Liability, to be Paid 1.82M USD -76.5%
Property, Plant and Equipment, Gross 75.5M USD -1.59%
Operating Lease, Liability, Current 1.22M USD -77.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 536K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.28M USD -77.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +20.2%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 81K USD -78.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 543K USD -60.2%
Deferred Tax Assets, Operating Loss Carryforwards 30.7M USD +16.2%
Current Income Tax Expense (Benefit) 336K USD +16.7%
Unrecognized Tax Benefits 2.73M USD +164%
Operating Lease, Payments 5.48M USD +15%
Additional Paid in Capital 683M USD +2.8%
Amortization of Intangible Assets 274K USD -43.6%
Depreciation, Depletion and Amortization 18.8M USD +4.43%
Deferred Tax Assets, Net of Valuation Allowance 392K USD -80.2%
Share-based Payment Arrangement, Expense 36.7M USD -22.5%